Clinical Characteristics, Treatment, and Prognosis of Amoxicillin-Induced AGEP/ALEP

Table 4

Treatment and prognosis of the 46 patients included.

Parameter	Result
Treatment
Discounted	44 (95.7%)
Unspecified	2 (4.3%)
Systemic corticoid	26 (56.5%)
Topical corticosteroids	13 (28.3%)
Antihistamines	10 (21.7%)
Topical antibiotic therapy	4 (8.7%)
Etanercept	1 (2.2%)
Retinoic acids	3 (6.5%)
Intravenous immunoglobulin	1 (2.2%)
Outcome
Resolved	44 (95.7%)
Unspecified	2 (4.3%)
Recovery time (37)^a
Days	10 (2, 42)^b
AGEP type
AGEP	37 (80.4%)
ALEP	9 (19.6%)
EuroSCAR AGEP score
5–7	19 (41.3%)
8–12	27 (58.7%)

AGEP: acute generalized exanthematous pustulosis; ALEP: acute localized exanthematous pustulosis; EuroSCAR: European case-control surveillance of severe cutaneous adverse reactions. ^aThe number of patients out of 46 about whom information regarding this particular parameter was provided. ^bMedian (minimum-maximum). 1–4: possible; 5–7: probable; 8–12 points: definite.